Dr. Ashish Vala, M.D

NPI: 1225267412
Total Payments
$3,022
2024 Payments
$154.76
Companies
35
Transactions
152
Medicare Patients
3,345
Medicare Billing
$1.1M

Payment Breakdown by Category

Food & Beverage$2,895 (95.8%)
Travel$127.53 (4.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,895 151 95.8%
Travel and Lodging $127.53 1 4.2%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $596.50 29 $0 (2023)
DePuy Synthes Sales Inc. $281.77 12 $0 (2024)
UCB, Inc. $278.46 13 $0 (2023)
Pacira Pharmaceuticals Incorporated $251.72 6 $0 (2024)
Horizon Pharma plc $232.80 23 $0 (2018)
Arbor Pharmaceuticals, Inc. $225.66 15 $0 (2022)
Novartis Pharmaceuticals Corporation $223.44 11 $0 (2021)
Celgene Corporation $100.18 1 $0 (2017)
Bioventus LLC $90.21 5 $0 (2023)
Ferring Pharmaceuticals Inc. $70.81 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $154.76 8 DePuy Synthes Sales Inc. ($49.95)
2023 $602.85 21 Pacira Pharmaceuticals Incorporated ($229.48)
2022 $194.73 10 Amgen Inc. ($91.86)
2021 $561.91 30 Amgen Inc. ($152.40)
2020 $299.00 17 Arbor Pharmaceuticals, Inc. ($73.81)
2019 $252.07 14 Amgen Inc. ($108.84)
2018 $472.42 28 DePuy Synthes Sales Inc. ($176.21)
2017 $484.41 24 Horizon Pharma plc ($109.54)

All Payment Transactions

152 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
09/27/2024 Avanos Medical TRIVISC SODIUM HYALURONATE (Device) Food and Beverage In-kind items and services $14.50 General
Category: PAIN MANAGEMENT
09/19/2024 DePuy Synthes Sales Inc. ORTHOVISC (Device), MONOVISC Food and Beverage In-kind items and services $29.65 General
Category: Sports Early Intervention
09/13/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $13.89 General
Category: CEREBROVASCULARCNS
08/20/2024 Fidia Pharma USA Inc. HYMOVIS (Device) Food and Beverage In-kind items and services $21.48 General
Category: OSTEOARTHRITIS
06/12/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $15.98 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
05/08/2024 DePuy Synthes Sales Inc. MONOVISC (Device), ORTHOVISC Food and Beverage In-kind items and services $20.30 General
Category: Sports Early Intervention
04/05/2024 Pacira Pharmaceuticals Incorporated Exparel (Drug), Iovera, Zilretta Food and Beverage In-kind items and services $22.24 General
Category: Pain Management
03/21/2024 Ferring Pharmaceuticals Inc. EUFLEXXA (Device) Food and Beverage In-kind items and services $16.72 General
Category: ORTHOPEDICS
12/02/2023 IBSA Pharma Inc. LICART (Drug), TIROSINT Food and Beverage Cash or cash equivalent $16.96 General
Category: non-opioid analgesic
11/15/2023 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $31.72 General
Category: Inflammation
11/08/2023 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $15.60 General
Category: Bone Health
10/28/2023 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $25.22 General
Category: Pain Management
10/28/2023 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $8.97 General
Category: Pain Management
10/27/2023 Pacira Pharmaceuticals Incorporated Iovera (Device) Travel and Lodging In-kind items and services $127.53 General
Category: Pain Management
10/27/2023 Pacira Pharmaceuticals Incorporated Iovera (Device) Food and Beverage In-kind items and services $41.45 General
Category: Pain Management
10/05/2023 Bioventus LLC GELSYN-3 (Device) Food and Beverage In-kind items and services $20.38 General
Category: Not Applicable
09/20/2023 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $26.49 General
Category: Immunology
09/15/2023 Pacira Pharmaceuticals Incorporated Iovera (Device), Zilretta Food and Beverage In-kind items and services $26.31 General
Category: Pain Management
08/02/2023 Alvogen Inc TERIPARATIDE (Drug) Food and Beverage In-kind items and services $23.96 General
Category: OSTEOPOROSIS
07/12/2023 Alexion Pharmaceuticals, Inc. STRENSIQ (Biological) Food and Beverage In-kind items and services $23.36 General
Category: Rare Disease
06/28/2023 Teleflex LLC UROLIFT (Device) Food and Beverage In-kind items and services $21.38 General
Category: Interventional Urology
06/21/2023 Kiniksa Pharmaceuticals, Ltd. Arcalyst (Drug) Food and Beverage Cash or cash equivalent $22.11 General
Category: Not Applicable
06/13/2023 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $26.67 General
Category: Immunology
05/31/2023 Ethicon US, LLC N/A (Device) Food and Beverage In-kind items and services $42.03 General
Category: Endo-Mechanical
05/16/2023 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $30.29 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 829 12,109 $1.1M $234,688
2022 12 702 12,115 $929,551 $295,170
2021 13 897 11,296 $920,847 $338,773
2020 13 917 6,020 $662,308 $200,570
Total Patients
3,345
Total Services
41,540
Medicare Billing
$1.1M
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J7331 Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg Office 2023 76 6,520 $338,520 $74,656 22.1%
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance Office 2023 140 683 $193,734 $52,841 27.3%
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg Office 2023 43 3,336 $333,600 $44,510 13.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 173 430 $98,860 $38,926 39.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 52 80 $18,924 $5,144 27.2%
73564 X-ray of knee, 4 or more views Office 2023 87 143 $18,304 $4,875 26.6%
73721 Mri scan of leg joint without contrast Office 2023 18 21 $35,910 $3,560 9.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 35 35 $6,140 $2,899 47.2%
72148 Mri scan of lower spinal canal without contrast Office 2023 16 16 $25,760 $2,535 9.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 13 13 $3,120 $1,547 49.6%
72100 X-ray of lower and sacral spine, 2-3 views Office 2023 33 34 $4,590 $936.53 20.4%
73030 X-ray of shoulder, minimum of 2 views Office 2023 26 32 $3,040 $855.16 28.1%
73502 X-ray of hip, 2-3 views Office 2023 17 22 $2,970 $799.11 26.9%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 100 744 $22,320 $602.78 2.7%
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg Office 2022 68 5,280 $360,000 $127,159 35.3%
J7331 Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg Office 2022 52 4,860 $225,990 $68,645 30.4%
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance Office 2022 118 619 $176,250 $47,616 27.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 138 310 $48,050 $29,609 61.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 86 144 $15,270 $9,096 59.6%
72148 Mri scan of lower spinal canal without contrast Office 2022 19 19 $30,590 $3,155 10.3%
73721 Mri scan of leg joint without contrast Office 2022 16 18 $30,780 $2,708 8.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 40 40 $6,200 $2,697 43.5%
73564 X-ray of knee, 4 or more views Office 2022 51 72 $9,216 $2,365 25.7%
73030 X-ray of shoulder, minimum of 2 views Office 2022 20 32 $3,040 $856.84 28.2%
72114 X-ray lower and sacral spine, minimum of 6 views Office 2022 13 13 $2,925 $636.23 21.8%

About Dr. Ashish Vala, M.D

Dr. Ashish Vala, M.D is a Family Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225267412.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Vala, M.D has received a total of $3,022 in payments from pharmaceutical and medical device companies, with $154.76 received in 2024. These payments were reported across 152 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,895).

As a Medicare-enrolled provider, Vala has provided services to 3,345 Medicare beneficiaries, totaling 41,540 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Sports Medicine
  • Location Sugar Land, TX
  • Active Since 07/08/2009
  • Last Updated 05/29/2025
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1225267412

Products in Payments

  • Enbrel (Biological) $435.36
  • Cimzia (Drug) $278.46
  • Iovera (Device) $229.48
  • Horizant (Drug) $225.66
  • COSENTYX (Biological) $223.44
  • Otezla (Drug) $206.77
  • MONOVISC (Device) $159.56
  • VIMOVO (Drug) $152.33
  • ORTHOVISC (Device) $122.21
  • EUFLEXXA (Device) $70.81
  • AUTOFILL (Device) $67.00
  • HYMOVIS (Device) $57.58
  • RAYOS (Drug) $56.23
  • SAPHNELO (Biological) $54.18
  • N/A (Device) $42.03
  • EVENITY (Biological) $37.24
  • PENNSAID (Drug) $36.97
  • GELSYN 3 (Device) $35.22
  • GELSYN-3 (Device) $32.34
  • Zilretta (Drug) $29.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Sugar Land